Update

medicine

COVID-19 Update: Medicine Hat passes mandatory mask bylaw | 1,685 new cases, 10 deaths



a person standing in front of a sunset: Araleigh Cranch adjusts her mask watching the sunset on Crescent Hill as the province announced plans for vaccines starting in January in Calgary on Wednesday, December 2, 2020.


© Provided by Calgary Herald
Araleigh Cranch adjusts her mask watching the sunset on Crescent Hill as the province announced plans for vaccines starting in January in Calgary on Wednesday, December 2, 2020.

With news on COVID-19 happening rapidly, we’ve created this page to bring you our latest stories and information on the outbreak in and around Calgary.

What’s happening now

How have you been impacted by COVID-19?

Postmedia is looking to speak with people who may have been impacted by the growing second wave of COVID-19 here in Alberta. Do you have a child or teen who caught COVID-19? Are you a front-line worker? Send us an email at [email protected] to tell us your experience, or send us a message via this form .



chart, histogram


© Provided by Calgary Herald


WHO looks at possible ‘e-vaccination certificates’ for travel



a close up of a painted wall:  This file photo taken on February 24, 2020 shows the logo of the World Health Organization (WHO) at their headquarters in Geneva.


© FABRICE COFFRINI
This file photo taken on February 24, 2020 shows the logo of the World Health Organization (WHO) at their headquarters in Geneva.

The World Health Organization (WHO) does not recommend countries issuing “immunity passports” for those who have recovered from COVID-19, but is looking at prospects of deploying e-vaccination certificates like those it is developing with Estonia.

Estonia and the United Nations health agency in October started a pilot project for a digital vaccine certificate – a “smart yellow card” – for eventual use in interoperable healthcare data tracking and to strengthen the WHO-backed COVAX initiative to boost vaccinations in developing countries.

Read more .

Health Canada to finish review on Pfizer vaccine candidate soon, federal govt. says



a close up of a bottle


© Provided by Calgary Herald


Canada is drawing closer to making a decision on a leading COVID-19 vaccine candidate, Health Minister Patty Hajdu said Wednesday as the federal government continued to face pressure to deliver on doses amid mounting cases and deaths.

In a series of Twitter messages, Hajdu described the United Kingdom’s decision to authorize the vaccine made by Pfizer and its German partner BioNTech as “encouraging.”

“Health Canada’s review of this candidate is ongoing, and is expected to be completed soon,” she wrote.

“Making sure a COVID-19 vaccine is safe before approving it is Health Canada’s priority, and when a vaccine is ready, Canada will be ready.”

Read more .

Hockey team that picked up COVID in Alberta wreaks havoc in B.C. community



a person wearing a suit and tie:  File photo of B.C. Provincial Health Officer Dr. Bonnie Henry.


© DON CRAIG
File photo of B.C. Provincial Health Officer Dr. Bonnie Henry.

An old-timers hockey team travelled from the Interior Health region into Alberta and returned with sick players, provincial health officer Dr. Bonnie Henry said Wednesday.

Those players then spread the disease to dozens of people, including family and workmates.

“I can tell you that it was several dozen families that were infected. Several businesses affected, long-term care was affected,” said Henry.

Read more .

Medicine Hat passes mandatory mask bylaw



a sign in front of a brick building:  Medicine Hat’s welcome sign sits on the east side of the city on Wednesday, August 22, 2012.


© Postmedia Archives
Medicine Hat’s welcome sign sits on the east side of the city on Wednesday, August 22, 2012.

Medicine Hat city council passed a mandatory face covering bylaw on Wednesday night.

Read More
fitness

Pep Guardiola provides crucial update on Sergio Aguero fitness

Following Manchester City’s dominant 5-0 victory over visitors Burnley, Pep Guardiola revealed why Sergio Aguero was left out of the team entirely – despite a return from injury on Wednesday night against Olympiacos.

According to the City boss, Aguero had ‘niggles’ in his knee, and Guardiola decided that the Argentine star should rest. He stated that the 32-year-old ‘woke up with a few problems‘ and must train further before he is back in the squad.

Speaking to BT Sport, Guardiola clarified that the Aguero’s knee injury had serious implications on the striker. Hence, they want to be careful with the recovery process. The latter is expected to join the squad in the training when he is fully fit.

Speaking on the entire situation surrounding Aguero, Pep Guardiola said, “With Sergio, it depends on how he wakes up. He made good training sessions but then had some niggles in his knee. It is day-by-day and yesterday I decided not to select him because he needs training and this morning he woke up with a little problem in his knee and he could not train.”

EnR100IXIAEold8

The City boss continued, “We know that the injury that he had is not easy for the recovery and we have to handle it as well as possible, and when he will be ready, he will start to train with us and play.”

Along with Aguero, Aymeric Laporte and Oleksandr Zinchenko Nathan were also rested for the match owing to squad rotation, while Nathan Ake is not quite 100% fit following his return to training after a hamstring injury.

That said, Manchester City are looking forward to training with all the first-team players ahead of the next weekend. 

—–

Follow us on Twitter for all the latest news: @City_Xtra

(function(d, s, id){ var js, fjs = d.getElementsByTagName(s)[0]; if (d.getElementById(id)) {return;} js = d.createElement(s); js.id = id; js.src = "https://connect.facebook.net/en_US/sdk.js"; js.defer = true // js.src = "//connect.facebook.net/en_US/sdk/debug.js"; fjs.parentNode.insertBefore(js, fjs); }(document, 'script', 'facebook-jssdk'));

Source Article

Read More
fitness

Frank Lampard provides positive Kai Havertz fitness update ahead of Rennes clash

Frank Lampard is hopeful that Chelsea midfielder Kai Havertz will travel to France for their Champions League clash against Rennes on Tuesday.

Havertz has been out after he tested positive for coronavirus earlier this month prior to the home win against Rennes. 

He returned to individual training this week and has been building up his fitness following a short period on the sidelines. 

But Lampard is hoping to have the 21-year-old available for their trip to France and that he’s available to get some minutes.

“I hope he is available [for Rennes]. He’s been in for a few days now doing some individual work and he’s looked pretty good,” said Lampard. 

“Kai is a naturally fit boy so I hope to have him travelling with us to Rennes and maybe he’ll get some minutes. I’m not sure exactly how many because it was a two-week isolation but he looks in good shape.” 

On any further injury news ahead of Tuesday’s clash, Lampard added that he will closely monitor the rest of the squad before making any selection decisions.

“I’ll make a decision whether to make changes or not depending on how the recovery looks. We have people like Ben Chilwell, who has had a back problem, and players who played a lot of international minutes so we’ll have to see how they are.”

———-

Follow Absolute Chelsea on: Twitter | Facebook | Instagram | YouTube

(function(d, s, id){ var js, fjs = d.getElementsByTagName(s)[0]; if (d.getElementById(id)) {return;} js = d.createElement(s); js.id = id; js.src = "https://connect.facebook.net/en_US/sdk.js"; js.defer = true // js.src = "//connect.facebook.net/en_US/sdk/debug.js"; fjs.parentNode.insertBefore(js, fjs); }(document, 'script', 'facebook-jssdk'));

Source Article

Read More
fitness

Andy Robertson provides update on his fitness ahead of Liverpool vs Leicester

Liverpool v Leicester: Premier League match preview

UP NEXT

UP NEXT

Andy Robertson says he is “fully fit and ready to go” for Liverpool’s top of the table clash with Leicester this weekend after shaking off his injury concern.

The Reds’ left-back was a doubt for Sunday’s meeting at Anfield after an intense fortnight of fixtures for Scotland, having already gone into the international break nursing an issue.

Liverpool are already down to the bare bones amid their ongoing injury crisis – particularly in defence – but Robertson insists he is fine to play a part.



Andrew Robertson holding a football ball: Robertson is fit to play against Leicester this weekend


© Liverpool FC via Getty Images
Robertson is fit to play against Leicester this weekend

“Yeah, I feel fit, feel ready to go,” Robertson told Liverpool’s official website on Friday. “I think I just got a tighter hamstring than usual against Man City, first and foremost.

“Then obviously the game on Thursday for Scotland was a huge one and 120 minutes and penalties had took its toll on me.

“Sunday, I wasn’t ready and just took a bit more time to recover from the game. But there wasn’t any real concerns about it.



MANCHESTER, ENGLAND - NOVEMBER 08: Andrew Robertson of Liverpool in action during the Premier League match between Manchester City and Liverpool at the Etihad Stadium on November 8, 2020 in Manchester, United Kingdom. Sporting stadiums around the UK remain under strict restrictions due to the Coronavirus Pandemic as Government social distancing laws prohibit fans inside venues resulting in games being played behind closed doors. (Photo by Visionhaus)


© Visionhaus
MANCHESTER, ENGLAND – NOVEMBER 08: Andrew Robertson of Liverpool in action during the Premier League match between Manchester City and Liverpool at the Etihad Stadium on November 8, 2020 in Manchester, United Kingdom. Sporting stadiums around the UK remain under strict restrictions due to the Coronavirus Pandemic as Government social distancing laws prohibit fans inside venues resulting in games being played behind closed doors. (Photo by Visionhaus)

“It was just the [risk] of doing anything worse to the hamstring was quite high on Sunday and the manager had made the call not to play me. Wednesday, I was good to go. Now I’m ready to go for Sunday, I feel fully fit, I feel ready.”

He added: “I know some people were quite concerned but I suppose with the amount of injuries we’ve had, people have become used to it. But I’m fully fit and ready to go.”

Robertson’s verdict will come as a welcome boost to manager Jurgen Klopp, who is already without three of his regular back four for the visit of Brendan Rodgers’ side.



The Reds' left-back working on his fitness in the gym at Liverpool's new Kirkby HQ


© Liverpool FC via Getty Images
The Reds’ left-back working on his fitness in the gym at Liverpool’s new Kirkby HQ


Virgil van Dijk and Joe Gomez are both ruled out with long-term injuries, while Trent Alexander-Arnold is still a couple of weeks away from returning to fitness.

Klopp is also hopeful Fabinho will be fit to feature in some capacity, and the Brazilian is expected to be involved.

Liverpool were also hit with the double blow of losing Jordan Henderson to a thigh strain, with Mohamed Salah also sidelined due to him contracting coronavirus.

Source Article

Read More
fitness

‘Tomorrow is too soon’ – Neil Lennon gives fitness update on key Celtic player ahead of Hibs clash

Neil Lennon takes his Celtic team to Edinburgh tomorrow to face former club HIbs
Neil Lennon takes his Celtic team to Edinburgh tomorrow to face former club HIbs

Previewing the match against his former employers, Hoops boss Neil Lennon gave an update on the fitness of his players following the international break.

Lennon said: “We’ve no fresh injuries from the internationals which is great. We’re really pleased to have them back in good spirits.

“Jeremie Frimpong is fine; there’s no ligament damage, and he’s been back training for a few weeks now.

Sign up to our Hibs football newsletter

The i newsletter cut through the noise

“Kristoffer Ajer may not be fit for tomorrow but definitely this week, whether it be Sparta Prague or Ross County. He’s started training and feeling good but tomorrow’s too soon for him.”

Declaring the clash in the Capital an “important game”, Lennon added: “We’ve got a massive run of games now. It’s good to have a healthy squad, and introduce some players back.

“If we can pick up where we left off, I’ll be pleased.”

A message from the Editor:

Thank you for reading this article. We’re more reliant on your support than ever as the shift in consumer habits brought about by Coronavirus impacts our advertisers.If you haven’t already, please consider supporting our trusted, fact-checked journalism by taking out a digital subscription.

Source Article

Read More
medicine

Schwazze, Formerly Operating as Medicine Man Technologies, Inc., Provides Business Update and Announces Strong Third Quarter 2020 Financial Results

DENVER–(BUSINESS WIRE)–Schwazze, formerly operating as Medicine Man Technologies Inc. (OTCQX:SHWZ) (“Schwazze ” or “the Company”), today provided a business update and announced strong financial results for its third quarter ended September 30, 2020.

Justin Dye, Chairman and Chief Executive Officer of Schwazze shared, “We are pleased with our progress in the third quarter. We continued to grow revenue and meaningfully narrow our net loss. Our third quarter performance demonstrates the team’s ability to implement our operating playbook and successfully integrate strategically attractive and accretive acquisitions such as Mesa Organics and Purplebee’s, which have proven to be an excellent strategic fit, into our operations.”

Dye continued, “We are eager to complete our acquisitions of Star Buds’ 14 Colorado locations during the fourth quarter. Star Buds is one of the most recognized and successful retail cannabis operators in North America. These acquisitions position us to become a cannabis leader in Colorado by combining their industry expertise with our best-in-class playbook. Together, we are creating the next era of cannabis that lowers the barrier of acceptance for mainstream America and accelerates innovation in health, happiness and quality of life for consumers.”

Business Update

  • On November 5, 2020, the Company announced that it has received satisfactory proof of funds acknowledgement from Star Buds in anticipation of closing the pending transactions. This acknowledgment enables companies to begin preparing for a fourth quarter 2020 closing of the acquisitions of 13 retail operations located throughout the Colorado front-range and one cultivation facility in Denver.
    • Star Buds is one of the most recognized and successful retail cannabis operators in North America based on revenue-per-location and profit. Upon completion of this transaction, the Company will be one the first publicly traded companies with full seed to sale operations in Colorado consisting of 17 dispensaries, manufacturing, and cultivation.
    • Based on the consolidated, unaudited 2019 results the Company received from Star Buds, these acquisitions collectively earned approximately $50M in revenue with a strong EBITDA margin.
    • The proforma revenue for the combined companies for 2020 will be approximately $90M and the combined companies will be profitable and cash flow positive after the completion of the acquisition.
  • On September 9, 2020, the Company announced that Nirup Krishnamurthy, Chief Integration and Information Officer, was named Chief Operating Officer, and Jeff Garwood, former GE executive, was appointed to the Schwazze Board of Directors.
    • Nirup Krishnamurthy has since assumed oversight of Schwazze’s business units including retail, manufacturing, cultivation, wholesale sales, and marketing to drive operational excellence throughout field operations. He has also continued to be responsible for the alignment and prioritization of the ongoing integration of the Company’s acquisitions and for driving technology innovation across the organization. Krishnamurthy joined Schwazze earlier this year, bringing more than 25 years of experience in operations, innovation, technology, integration and M&A at Fortune 500 companies including United Airlines, Northern Trust Bank and former grocery retailer The Great Atlantic & Pacific Tea Company (A&P).
    • Jeff Garwood is a recognized visionary business leader bringing 30 years of extensive experience across
Read More
fitness

Oculus Quest update adds fitness tracker app, and Quest 2 gets 90Hz games

oculusmovescreenshot1.png

Oculus Move is a fitness-tracking app to look at how much you’ve been working out in VR.


Facebook

Facebook’s Oculus Quest VR platform has continued adding updates over the past year and a half, but its latest one could turn it into a full-fledged workout ecosystem for the winter. The Oculus Quest 2 is also getting visual upgrades to support 90Hz refresh rates in games and for PC use. It’s all part of a software update announced today.

Oculus Move, a new fitness dashboard that tracks movement and estimated calorie burn across multiple VR exercise apps, will be rolling out next week as part of a Quest and Quest 2 software update. Move was announced earlier this fall at Facebook’s virtual Connect conference during the launch of the Quest 2.

Oculus Quest 2

Scott Stein/CNET

The newest software update will also unlock smoother 90Hz VR support in the Quest 2 for games that choose to take advantage. The first games with updates, according to Facebook, will be Superhot, Echo VR, Beat Saber, Vacation Simulator, Job Simulator, Racket: Nx and Space Pirate Trainer. 

90Hz VR is the standard for PC VR, and the Quest and Quest 2 can already work as PC VR headsets with a USB-C cable. That PC-connected feature, called Oculus Link, is also getting 90Hz support on the Quest 2.


Now playing:
Watch this:

Oculus Quest 2 is better and cheaper… with one Facebook…



8:56

Source Article

Read More
fitness

Oculus Quest update adds 90Hz support for games, built-in fitness tracker

The platform-wide 90Hz refresh rate support the Oculus team promised for the Quest 2 has arrived. Oculus has rolled out a major software upgrade for the Quest, and it’ll enable Home, Guardian and Passthrough to run at 90Hz by default. It also means 90Hz gaming on the VR headset— in fact, the Facebook-owned subsidiary is now allowing developers to start shipping Quest titles with native 90Hz support. Existing VR games like SUPERHOT, Echo VR, Beat Saber, Vacation Simulator, Job Simulator, Racket: Nx and Space Pirate Trainer will also be updated with 90Hz capability in the near future.

Oculus shipped the Quest 2 headset with 72Hz refresh rates. Before this update, you could only opt into the 90Hz mode for the Home Environment, Explore, Store, Browser and Oculus TV through the platform’s Experimental Features pane. Now that 90Hz is officially here, you can expect smoother VR experiences throughout, which could also mean lesser chances and fewer instances of motion sickness.

The team is also bringing 90Hz support to the Oculus Link, allowing you to toggle between 72Hz, 80Hz and 90Hz from the Oculus PC App. Oculus launched Link in 2019 to give you a way to connect a Quest headset to gaming PCs with a cable. By connecting to a PC, you’ll be able to access Rift experiences on the standalone VR headset. The feature has now moved out of beta and will be available more broadly.

In addition to enabling 90Hz gaming, the software update also brings Oculus Move to the Quest and Quest 2. Oculus Move, which Facebook first revealed in September, is a built-in fitness tracker for the platform that can help you track how may calories you’ve burned and how long you’ve been active while playing VR games like Beat Saber. It’ll roll out gradually, though, so you may need to wait a bit before it hits your device.

Oculus
Oculus

Finally, Oculus will release App Gifting later this month, letting you purchase games or experiences from the Oculus Store and then send them to a friend. To take advantage of the new feature, just look for the “Buy for a Friend” button on the website or find it in the more menu on the mobile app.

Source Article

Read More
medicine

Latest Update on Drug (Medicine) Dispenser Market by Emerging Trends, Share, Growth Rate, Opportunities And Market Forecast To 2021

The MarketWatch News Department was not involved in the creation of this content.

New York, United States, Tue, 10 Nov 2020 09:12:58 / Comserve Inc. / — Global drug (medicine) dispenser market is expected to register a robust CAGR over the forecast period. Moreover, the global drug (medicine) dispenser market is expected to reach at notable revenue by the end of 2021.

The global drug (medicine) dispenser market is segmented into application such as hospitals, pharmacies and homecare. Among these segments, homecare segment is expected to grow at maximum pace during the forecast period. The rise of the homecare segment is backed by the increasing demand for drug (medicine) dispenser by patients who have to response to drugs on daily basis and especially by patients who have memory deficiencies. However, it can be used in hospitals and pharmacies also to reduce chances of medication error.

Global drug (medicine) dispenser market is expected to register a robust CAGR over the forecast period. Moreover, the global drug (medicine) dispenser market is expected to reach at notable revenue by the end of 2021. Factor such as technological advancements in medical devices and increasing geriatric population across the globe are expected to be the dynamic factors behind the growth of this segment during the forecast period.

The North America segment by region accounted for major share of global drug (medicine) dispenser market in 2015.Moreover, North America drug (Medicine) dispenser is poised to display substantial growth during the forecast period owing to a number of factors such as swelled disposable income, high spending on healthcare and increasing adoption of advanced medical devices in this region.

Download Sample of This Strategic Report @ https://www.researchnester.com/sample-request-73

Increased Geriatric Population

Factors such as increasing older population and rising incidence of age-related memory weakness are anticipated to fuel the demand for drug (medicine) dispenser over the forecast period. Furthermore, drug (medicine) dispenser helps aged people to maintain their regular medication and avoid any medication error. This factor is envisioned to escalate the growth of Drug (Dispenser) Market in Future.

Technological Advancements in Medical Devices

Demand for automated medication dispensing system is increasing due to its advantages such as prevention of medication error, easy controlling and better customization. Additionally, swift advancements in healthcare technologies and concerns regarding patient’s health and medication in hospitals is also increasing the demand for drug (medicine) dispenser in hospitals which in turn likely to foster the growth of global drug (medicine) dispenser market over the forecast period.

Although, high repair and maintenance cost of advanced medication dispenser and slow adoption rate in under developed countries are some of the factors that are likely to obstruct the growth of the drug (medicine) dispenser market in the near future.

Further, for the in-depth analysis, the report encompasses the industry growth drivers, restraints, supply and demand risk, market attractiveness, BPS analysis and Porter’s five force model.

Curious about this latest version of report? Obtain Report Details @ https://www.researchnester.com/reports/global-drug-medicine-dispenser-market-analysis-opportunity-outlook-2021/73

This report also provides the existing competitive scenario of some of

Read More
medicine

Editas Medicine Announces Third Quarter 2020 Results and Update

EDIT101 for LCA10 BRILLIANCE trial adult low-dose cohort completed

EDIT-301 for sickle cell disease on track for IND filing by end of 2020

EDIT-201 for solid tumors preclinical data to be presented at SITC and ASH

Cash, cash equivalents, and marketable securities of $541 million as of September 30, 2020

CAMBRIDGE, Mass., Nov. 05, 2020 (GLOBE NEWSWIRE) — Editas Medicine, Inc. (Nasdaq: EDIT), a leading genome editing company, today reported business highlights and financial results for the third quarter of 2020.

“We were pleased to regain full operating control of our ocular programs per our new agreement with AbbVie, which provides us with important flexibility. We have finished dosing the first cohort with EDIT-101 in the landmark BRILLIANCE trial and enrollment remains active,” said Cynthia Collins, Chief Executive Officer of Editas Medicine.

Ms. Collins continued, “The advancements in our ocular portfolio are complemented by the strategic development of our engineered cell medicines. We are on track to file the IND for EDIT-301 for sickle cell disease in the fourth quarter and are eager to present additional data on this potentially best-in-class medicine and our large-scale manufacturing process at the upcoming American Society of Hematology Annual Meeting. Substantial progress has also been made in the development of EDIT-201, an allogeneic NK cell medicine to treat solid tumors. Preclinical data to be presented at ASH show enhanced tumor killing with EDIT-201 compared to unedited NK cells, and additional data on this program will be featured at the upcoming Society for Immunotherapy of Cancer’s Annual Meeting.”

Recent Achievements and Outlook

In Vivo CRISPR Medicines  

  • EDIT-101 for LCA10
    BRILLIANCE Phase1/2 adult low-dose cohort completed
    Editas Medicine (Company) has completed dosing of the first cohort of adult patients with visual light perception only administered the low dose of EDIT-101. Trial enrollment remains active but has experienced a slowdown due to the ongoing impact of the COVID-19 pandemic. 

  • Ocular Medicines
    Regained full control of ocular medicines
    Editas Medicine terminated its 2017 agreement with Allergan, now part of AbbVie, and entered a new agreement with AbbVie that returned development and commercialization rights for ocular medicines to Editas Medicine. As part of the new agreement, AbbVie has transferred supplier contracts, including with the contract research organization (CRO), as well as sponsorship of the investigational new drug application (IND) for the BRILLIANCE Phase 1/2 clinical trial to Editas Medicine. The Company plans to continue to advance ocular medicines, including EDIT-101 for Leber congenital amaurosis 10 (LCA10).

Ex Vivo CRISPR Cell Medicines  

  • EDIT-301 for Sickle Cell Disease and Beta-Thalassemia
    On track for IND filing by end of 2020
    Editas Medicine continues to prepare for a Phase 1/2 clinical trial evaluating EDIT-301 for the treatment of sickle cell disease. The Company has completed preclinical toxicology studies, identified a lead principal investigator, and engaged a CRO. Clinical trial materials are being manufactured by Editas Medicine. The Company remains on track to file an IND for the treatment of sickle cell disease by

Read More